A Case Study of Elevated Lp(a) Levels and Increased ASCVD Risk

Global Heart Hub endorses the Brussels International Declaration on Lp(a)

Global Heart Hub endorses the Brussels International Declaration on Lp(a)Global Heart Hub was delighted to join leading international stakeholders as a proud partner of the inaugural Lp(a) Global Summit which took place in Brussels on March 24th & 25th calling for urgent action on one of the most under-recognised threats to cardiovascular health – elevated Lipoprotein(a). Hosted by the FH Europe Foundation, the event unveiled the Brussels Intern…

A Case Study of Elevated Lp(a) Levels and Increased ASCVD Risk

Experts discuss an example illustrating the association between lipoprotein(a) (Lp[a]) levels and atherosclerotic cardiovascular disease (ASCVD) risk and explore how this example can inform our understanding of Lp(a) and ASCVD risk on a population level.